The future facility will also house a state-of-the-art R&D pilot plant to manufacture medicines for clinical trials ...
That involved working with GSK’s R&D, supply-chain, and commercial units ... improving the predictability of clinical trials. Using 60 digital twins across the company, GSK is also able to ...
GSK has pledged to 100% use of renewable across the company by 2025, and an 80% reduction in carbon emissions by 2030 en route to net zero across all its supply chain – including purchased goods ...